Columnist Desiree Lama has always known she wanted to help people; now she is achieving that goal through MS advocacy.

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Vaccination didn't increase the risk of children or adolescents being diagnosed with pediatric MS within five years, a study ...

Tiziana's Phase 2 trial testing foralumab for nonactive secondary progressive multiple sclerosis (SPMS) has added six U.S.

Children with MS from poorer families or other disadvantaged circumstances tend to have more inflammation and brain damage, a ...

When faced with the obstacle course that is MS, columnist Ben Hofmeister remembers his strategy while in the Army Special Forces: Don't quit.

Nabiximols and other cannabis-based treatments were seen to work well at controlling spasticity, though responses vary among ...